156 related articles for article (PubMed ID: 1636575)
1. Plasma plasminogen activator inhibitor activity and tissue plasminogen activator levels in patients with unstable angina and those with coronary spastic angina.
Masuda T; Yasue H; Ogawa H; Misumi I; Sakamoto T; Okubo H; Miyao Y; Kato H
Am Heart J; 1992 Aug; 124(2):314-9. PubMed ID: 1636575
[TBL] [Abstract][Full Text] [Related]
2. Platelet hyperaggregability persists even after the improvement of increased blood coagulation and impaired fibrinolysis with the stabilization of symptoms in patients with unstable angina.
Miyamoto S; Ogawa H; Sakamoto T; Soejima H; Takazoe K; Shimomura H; Kajiwara I; Yoshimura M; Kugiyama K; Nakamura S; Ozaki Y
Int J Cardiol; 2001; 80(2-3):235-42. PubMed ID: 11578720
[TBL] [Abstract][Full Text] [Related]
3. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina.
Miyamoto S; Kawano H; Takazoe K; Soejima H; Sakamoto T; Hokamaki J; Yoshimura M; Nakamura H; Yodoi J; Ogawa H
Thromb Res; 2004; 113(6):345-51. PubMed ID: 15226088
[TBL] [Abstract][Full Text] [Related]
4. Evidence for reduced fibrinolytic activity in unstable angina at rest. Clinical, biochemical, and angiographic correlates.
Zalewski A; Shi Y; Nardone D; Bravette B; Weinstock P; Fischman D; Wilson P; Goldberg S; Levin DC; Bjornsson TD
Circulation; 1991 May; 83(5):1685-91. PubMed ID: 1902406
[TBL] [Abstract][Full Text] [Related]
5. Transmyocardial fibrinolytic activity in patients with unstable angina pectoris.
Daniel WC; Meidell RS; Hillis LD; Lange RA
Coron Artery Dis; 1996 Jan; 7(1):45-9. PubMed ID: 8773432
[TBL] [Abstract][Full Text] [Related]
6. Plasma lipoprotein(a) levels and fibrinolytic activity in patients with unstable angina.
Okubo H; Yasue H; Ogawa H; Misumi I; Masuda T; Miyao Y; Sakamoto T
Jpn Circ J; 1993 Oct; 57(10):947-54. PubMed ID: 7901435
[TBL] [Abstract][Full Text] [Related]
7. Circadian fluctuations of tissue plasminogen activator antigen and plasminogen activator inhibitor-1 antigens in vasospastic angina.
Sakata K; Hoshino T; Yoshida H; Ono N; Ohtani S; Yokoyama S; Mori N; Kaburagi T; Kurata C; Urano T
Am Heart J; 1992 Oct; 124(4):854-60. PubMed ID: 1529901
[TBL] [Abstract][Full Text] [Related]
8. Tissue plasminogen activator release and plasminogen activator inhibitor levels in coronary artery disease.
Meyers DG; Haire WD; Rasmussen JK; Boyd EJ
Angiology; 1991 Jul; 42(7):561-7. PubMed ID: 1907440
[TBL] [Abstract][Full Text] [Related]
9. Endothelial tissue-type plasminogen activator release in coronary heart disease: Transient reduction in endothelial fibrinolytic reserve in patients with unstable angina pectoris or acute myocardial infarction.
Hoffmeister HM; Jur M; Ruf-Lehmann M; Helber U; Heller W; Seipel L
J Am Coll Cardiol; 1998 Mar; 31(3):547-51. PubMed ID: 9502633
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic variables in postmenopausal women with unstable coronary artery disease.
Nielsen NE; Logander E; Swahn E
J Thromb Thrombolysis; 2001 Dec; 12(3):217-23. PubMed ID: 11981104
[TBL] [Abstract][Full Text] [Related]
11. The dynamic changes of plasma tissue-type plasminogen activator level and the activity of its inhibitor during coronary vasospasm.
Aoyama T; Yui Y; Takatsu Y; Takahashi M; Murohara Y; Shirotani M; Yasumoto H; Morishita H; Kadota K; Sakaguchi K
Jpn Circ J; 1990 Sep; 54(9):1139-46. PubMed ID: 2125083
[TBL] [Abstract][Full Text] [Related]
12. Circadian variation in fibrinolytic activity in patients with variant angina.
Masuda T; Ogawa H; Miyao Y; Yu Q; Misumi I; Sakamoto T; Okubo H; Okumura K; Yasue H
Br Heart J; 1994 Feb; 71(2):156-61. PubMed ID: 8130024
[TBL] [Abstract][Full Text] [Related]
13. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina.
Wieczorek I; Ludlam CA; Fox KA
Am J Cardiol; 1994 Sep; 74(5):424-9. PubMed ID: 8059719
[TBL] [Abstract][Full Text] [Related]
14. [Blood coagulation and fibrinolysis in ischemic heart disease].
Sakamoto T; Ogawa H; Miyao Y; Yasue H
Rinsho Byori; 1994 Jan; 42(1):39-44. PubMed ID: 8107282
[TBL] [Abstract][Full Text] [Related]
15. Tissue plasminogen activator and plasminogen activator inhibitor-1 levels in patients with acute myocardial infarction and unstable angina.
Habib SS; Abdel Gader AG; Kurdi MI; Suriya MO; Al Aseri Z
J Pak Med Assoc; 2012 Jul; 62(7):681-5. PubMed ID: 23866515
[TBL] [Abstract][Full Text] [Related]
16. Circadian variation in plasma levels of free-form tissue factor pathway inhibitor antigen in patients with coronary spastic angina.
Misumi K; Ogawa H; Yasue H; Soejima H; Suefuji H; Nishiyama K; Takazoe K; Kugiyama K; Tsuji I; Kumeda K
Jpn Circ J; 1998 Jun; 62(6):419-24. PubMed ID: 9652317
[TBL] [Abstract][Full Text] [Related]
17. Association between plasmin activation system and intravascular ultrasound signs of plaque instability in patients with unstable angina and non-st-segment elevation myocardial infarction.
Gyöngyösi M; Glogar D; Weidinger F; Domanovits H; Laggner A; Wojta J; Zorn G; Iordanova N; Huber K
Am Heart J; 2004 Jan; 147(1):158-64. PubMed ID: 14691435
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous interventions alter the hemostatic profile of patients with unstable versus stable angina.
Yazdani S; Simon AD; Kovar L; Wang W; Schwartz A; Rabbani LE
J Am Coll Cardiol; 1997 Nov; 30(5):1284-7. PubMed ID: 9350928
[TBL] [Abstract][Full Text] [Related]
19. Correlation between coronary morphology and molecular markers of fibrinolysis in unstable angina pectoris.
Hoffmeister HM; Jur M; Helber U; Fischer M; Heller W; Seipel L
Atherosclerosis; 1999 May; 144(1):151-7. PubMed ID: 10381288
[TBL] [Abstract][Full Text] [Related]
20. Comparison of plasma tissue factor levels in unstable and stable angina pectoris.
Misumi K; Ogawa H; Yasue H; Soejima H; Suefuji H; Nishiyama K; Takazoe K; Kugiyama K; Tsuji I; Kumeda K; Nakamura S
Am J Cardiol; 1998 Jan; 81(1):22-6. PubMed ID: 9462600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
